Cargando…
Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
Nonalcoholic fatty liver disease (NAFLD) constitutes a major health concern with the increasing incidence of obesity and diabetes in many Western countries, reaching a prevalence of up to 30% in the general population. Animal models have played a vital role in elucidating the pathophysiological mech...
Autores principales: | Van Herck, Mikhaïl A., Vonghia, Luisa, Francque, Sven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691689/ https://www.ncbi.nlm.nih.gov/pubmed/28953222 http://dx.doi.org/10.3390/nu9101072 |
Ejemplares similares
-
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019) -
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
por: Vonghia, Luisa, et al.
Publicado: (2019) -
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019) -
Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
por: Van Herck, Mikhaïl A., et al.
Publicado: (2020) -
Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015)